Showing 4,481 - 4,500 results of 9,864 for search '"drug"', query time: 0.06s Refine Results
  1. 4481

    YOUTH RESTIVENESS IN NIGERIA: AN EVALUATION OF IKORODU LOCAL GOVERNMENT, LAGOS, NIGERIA by NIYI ADEGOKE, Odedokun Ezekiel Adeyemi, Odunayo Tolulope Ojo

    Published 2023-09-01
    “…The paper reveals that drug abuse, illiteracy, unemployment, poverty, and poor child up bringing among others are some of the causes by youth restiveness. …”
    Get full text
    Article
  2. 4482

    Zinc Transporters, Mechanisms of Action and Therapeutic Utility: Implications for Type 2 Diabetes Mellitus by Stephen A. Myers, Alex Nield, Mark Myers

    Published 2012-01-01
    “…This previously unexplored concept would raise a whole new area of research into the pathophysiology of insulin resistance and introduce a new class of drug target with utility for diabetes pharmacotherapy.…”
    Get full text
    Article
  3. 4483

    Antioxidant and Anti-Inflammatory Properties of Melatonin in Secondary Traumatic Brain Injury by Mariusz Sieminski, Michalina Reimus, Maria Kałas, Ewelina Stępniewska

    Published 2024-12-01
    “…Melatonin, a sleep–wake-cycle-regulating neurohormone, exerts strong antioxidant and anti-inflammatory effects and is well tolerated when used as a drug. Due to these properties, it is very reasonable to consider melatonin as a potential therapeutic molecule for TBI treatment. …”
    Get full text
    Article
  4. 4484

    Study on Preparation Technology and Physical Fingerprint of Chuilian Jianpi Granules Based on QbD by Guangjiao Zhou, Xiao-Wei Li, Jin-Cai Li, Xue-Hua Feng

    Published 2021-01-01
    “…The optimum formula conditions of Chuilian Jianpi granules were as follows: the dosage ratio of drug to adjuvant was 1 : 0.8, lactose:mannitol = 1.5 : 1, and the amount of wetting agent (90% ethanol) was 25% of the granules, with high-speed stirring granulation. …”
    Get full text
    Article
  5. 4485

    Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluation by Ali Ahmed Mahmoud Abdelhaleem, Ali Adel Ahmed, Maghrabi Ibrahim Abdullah

    Published 2015-06-01
    “…Co-amorphous dispersions were prepared using modified solvent evaporation methodology at drug/plasticizer stoichiometric ratios of 1:1, 1:1.5 and 1:2. …”
    Get full text
    Article
  6. 4486

    Shikonin Induces Glioma Necroptosis, Stemness Decline, and Impedes (Immuno)Proteasome Activity by Xianyun Qin, Lu Zhang, Jilan Liu, Yan Lu, Fuyao Zhou, Feng Jin

    Published 2024-01-01
    “…The discussion extends to the potential of Shikonin as a promising therapeutic agent in the management of gliomas, offering a novel avenue for drug development in this challenging clinical context.…”
    Get full text
    Article
  7. 4487

    Immunosenescence of Polymorphonuclear Neutrophils by Inga Wessels, Judith Jansen, Lothar Rink, Peter Uciechowski

    Published 2010-01-01
    “…This could form the basis for drug development in order to prevent or treat age-related diseases, and thus to unburden the public health systems.…”
    Get full text
    Article
  8. 4488

    Family support and adherence to treatment in people affected by tuberculosis by Cesar Raul Castro Galarza, Maritsa Julia Camarena Cristóbal, Ilse Faustina Fernandez Honorio

    Published 2020-10-01
    “…<p><strong>Background</strong>: Adherence to treatment in tuberculosis is relevant, both for its effect to be successful and to limit the emergence of drug resistance.<br /><strong>Objective</strong>: to determine the relationship between family support and adherence to treatment in patients with tuberculosis.…”
    Get full text
    Article
  9. 4489

    Exosomes, their sources, and possible uses in cancer therapy in the era of personalized medicine by Tomas Zemanek, Lubos Danisovic, Andreas Nicodemou

    Published 2024-12-01
    “…Recent advancements in exosome-based therapy have highlighted its utility in drug delivery and immunotherapy. This review examines the composition and sources of exosomes within the immune microenvironment of solid tumors and delves into the mechanisms and pathways through which exosomes impact immunotherapy. …”
    Get full text
    Article
  10. 4490

    Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia by Kunal Maini, Janice W. Hollier, Haley Gould, Victoria Bollich, John LaForge, Elyse M. Cornett, Amber N. Edinoff, Adam M. Kaye, Alan D. Kaye

    Published 2021-06-01
    “…Lumateperone tosylate is an FDA-approved drug that can be given only at the 42mg dose once daily with no titration requirements.…”
    Get full text
    Article
  11. 4491

    Solid Lipid Nanoparticles Based on L-Cysteine for Progesterone Intravaginal Delivery by Roberta Cassano, Sonia Trombino

    Published 2019-01-01
    “…For this reason, a material capable of ensuring the permanence of the formulation in the administration site for the time needed to guarantee the transmucosal absorption of the steroid was synthetized in order to reduce the number of administrations and to ensure an effective concentration of drug at the site of action. To this end, an ester, 2,3-dihydroxypropanoate of octadecyl (stearyl glycerine), containing two hydroxyl groups was initially synthesized. …”
    Get full text
    Article
  12. 4492

    Genipin Cross-Linked Chitosan-Polyvinylpyrrolidone Hydrogels: Influence of Composition and Postsynthesis Treatment on pH Responsive Behaviour by Chinyelumndu Jennifer Nwosu, Glenn Adam Hurst, Katarina Novakovic

    Published 2015-01-01
    “…Understanding the factors that influence the pH responsive behaviour of biocompatible cross-linked hydrogel networks is essential when aiming to synthesise a mechanically stable and yet stimuli responsive material suitable for various applications including drug delivery and tissue engineering. In this study the behaviour of intelligent chitosan-polyvinylpyrrolidone-genipin cross-linked hydrogels is examined as a function of their composition and postsynthesis treatment. …”
    Get full text
    Article
  13. 4493

    A Rare Case of Rivaroxaban Causing Delayed Symptomatic Hepatocellular Injury and Hyperbilirubinemia by Keith Glenn, Patrick Chen, Mustafa Musleh, Rao Pallivi, Melissa Grilliot

    Published 2017-01-01
    “…As Rivaroxaban has increased in popularity, it has been accompanied with a growing body of evidence displaying its ability to cause drug induced liver injury (DILI). Observation. A 74-year-old Caucasian female developed Rivaroxaban DILI two weeks after finishing a 14-day course. …”
    Get full text
    Article
  14. 4494

    Integration of Artificial Intelligence and Blockchain Technology in Healthcare and Agriculture by Sonali Vyas, Mohammad Shabaz, Prajjawal Pandit, L. Rama Parvathy, Isaac Ofori

    Published 2022-01-01
    “…Integrating these advanced approaches in agriculture is critical for managing food supply chains, drug supply chains, quality maintenance, and intelligent prediction. …”
    Get full text
    Article
  15. 4495

    Consequences of Hyperoxia and the Toxicity of Oxygen in the Lung by William J. Mach, Amanda R. Thimmesch, J. Thomas Pierce, Janet D. Pierce

    Published 2011-01-01
    “…Oxygen (O2) is life essential but as a drug has a maximum positive biological benefit and accompanying toxicity effects. …”
    Get full text
    Article
  16. 4496

    A Unique Case of Cardiac Arrest following K2 Abuse by Saif Ibrahim, Farah Al-Saffar, Thomas Wannenburg

    Published 2014-01-01
    “…We describe a case of out-of-hospital cardiac arrest temporally related to abuse of the synthetic cannabinoid street drug known as K2. To our knowledge, there are no previously documented cases of sudden cardiac death associated with synthetic cannabinoids although they have been linked to myocardial infarction in teenagers despite normal coronary angiography (Mir et al. (2011)).…”
    Get full text
    Article
  17. 4497

    Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy by Lorena Perrone, Carmela Matrone, Lalit P. Singh

    Published 2014-01-01
    “…Evidences have provided that after a period of poor glucose control insulin or diabetes drug treatment fails to prevent the development and progression of DR even when good glycemic control is reinstituted (glucose normalization), suggesting a metabolic memory phenomenon. …”
    Get full text
    Article
  18. 4498

    Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia by Pashtoon Murtaza Kasi, Mrinal M. Patnaik, Prema P. Peethambaram

    Published 2013-01-01
    “…Prescribing information available on manufacturer’s website for the drug warns us about possible severe sickle cell crises related to the medication but does not report the actual incidence or the use in patients with sickle cell trait. …”
    Get full text
    Article
  19. 4499

    Safe Handling of Food and Water in a Hurricane or Related Disaster by Ronald H. Schmidt, Keith L. Schneider, Renée M. Goodrich, Amarat Simonne, Douglas L. Archer

    Published 2005-10-01
    “…Recommendations have also been included from additional up-to-date sources such as the: Centers for Disease Control and Prevention (CDC), Environmental Protection Agency (EPA), Food and Drug Administration (FDA), Florida Department of Agriculture and Consumer Services (DOACS), Florida Department of Health (DOH), Federal Emergency Management Agency (FEMA), and American Red Cross. …”
    Get full text
    Article
  20. 4500

    Responsive nanomaterials in biomedicine, patent path and prospect analysis by Xinrui Liu, Hongmei Yuan

    Published 2025-02-01
    “…In recent years, responsive nanomaterials have demonstrated tremendous potential in biomedical applications due to their unique advantages in precise drug delivery and controlled release. For complex diseases such as cancer, chronic inflammation, and genetic disorders, traditional treatment methods are often limited by insufficient targeting and significant side effects. …”
    Get full text
    Article